SCHEMBL6663559

SCHEMBL6663559

O=c1nc(C=Cc2cc(Br)cc(Br)c2O)cc(-c2ccco2)[nH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 5/20 0.37
ERN1 O75460 1/20 0.36
LCK P06239 1/20 0.36
MEN1 O00255 7/20 0.36
KMT2A Q03164 7/20 0.36
MAPT P10636 6/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 3/20 0.35
GFER P55789 2/20 0.35
PTK6 Q13882 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
IDE P14735 1/20 0.35
CTSV O60911 1/20 0.35
CTSL P07711 1/20 0.35
KDM4E B2RXH2 3/20 0.35
ALDH1A1 P00352 3/20 0.35
PLA2G1B P04054 2/20 0.35
RECQL P46063 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6593751 0.82 CDC7 (0.45) POLBERN1LCKMEN1KMT2A
SCHEMBL6593747 0.82 CDC7 (0.45) POLBERN1LCKMEN1KMT2A
SCHEMBL6594950 0.76 ERN1 (0.45) POLBERN1LCKMEN1KMT2A
SCHEMBL6594952 0.76 ERN1 (0.45) POLBERN1LCKMEN1KMT2A
SCHEMBL6594964 0.75 ERN1 (0.44) POLBERN1LCKMEN1KMT2A
SCHEMBL6594962 0.75 ERN1 (0.44) POLBERN1LCKMEN1KMT2A
SCHEMBL6665810 0.75 TNF (0.64) POLBMEN1KMT2AMAPTSMN1; SMN2
SCHEMBL6665598 0.74 KDM4E (0.39) MEN1KMT2AMAPTSMN1; SMN2LMNA
SCHEMBL6594013 0.72 TNF (0.57) POLBERN1MEN1KMT2AMAPT
SCHEMBL6594011 0.72 TNF (0.57) POLBERN1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004016271-A1 PYRIMIDONES AS ANTIVIRAL AGENTS AXXIMA PHARMACEUTICALS AG (DE) 2004-02-26 WO claimed
WO-2004016271-A1 PYRIMIDONES AS ANTIVIRAL AGENTS AXXIMA PHARMACEUTICALS AG (DE) 2004-02-26 WO disclosed